Copyright ©The Author(s) 2019.
World J Gastroenterol. May 14, 2019; 25(18): 2188-2203
Published online May 14, 2019. doi: 10.3748/wjg.v25.i18.2188
Table 1 Effets of Saccharomyces boulardii CNCM I-745 on gut microbiota in various diseases
DiseaseTechniqueAlteration of the microbiotaEffet of S.boulardii CNCM I-745Ref.
Antibiotic treatment (mice)FISH and cytometryIncrease in Enterobacteriaceae and BacteroidesRapid return to normal for: Bacteroides, Clostridium cocoidesEubacterium rectale, PrevotellaPorphyromonas[67,71]
Drastic decrease in Clostridium cocoides and Eubacterium rectale
Chronic diarrhea (humans)Coring and FISHIncrease in BifidobaceriumEubacterium cylindrodes, Clostridium histolyticus etDecrease in Bacteroides and Roseburia[72]
Decrease in Bacteroides et Roseburia
Antibiotic Treatment (humans)SequencingIncrease in Parabacteroides and Escherichia/ShigellaReduces microbiota variations due to antibiotic treatment[74]
Decrease in Ralstonia
Antibiotic Treatment (women1)Corning and FISHDecrease in dominant microbiota:Clostridium cocoides, Eubacterium rectale, Bacteroides, Roseburia and Faecalibacterium prausnitziiGroup A/Sb: Increase in Bacteroides, Roseburia and Faecalibacterium prausnitzii[73]
Groupe Sb-A: Rapid return to normal